FDA NDC Directory · JSON-LD · Markdown

Miglustat

NDC 70710-2039 · HUMAN PRESCRIPTION DRUG · CAPSULE

Labeler / ManufacturerZydus Pharmaceuticals USA Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA219111
Dosage form / routeCAPSULE · ORAL
Active ingredientsMIGLUSTAT (100 mg/1)
Marketing started20250401
Package count1

External sources

Source: openFDA. Public-domain (CC0).